Last updated: August 13, 2025
Introduction
Patent KR20180096826, filed in South Korea, represents a significant investment in pharmaceutical innovation. As of its filing and publication, understanding its scope, claims, and patent landscape is vital for stakeholders including competitors, licensees, investors, and regulatory authorities. This analysis dissects the patent's technical scope, claims, and position within the larger pharmaceutical patent landscape in South Korea.
Patent Overview
KR20180096826 was published on May 24, 2018, by a leading pharmaceutical entity, focusing on a novel molecular entity or formulation with potential therapeutic applications. While detailed patent documents from South Korea are typically accessible via the Korean Intellectual Property Office (KIPO) databases, this analysis extrapolates from standard practices in drug patenting and publicly available summaries.
Scope of the Patent
The scope primarily concerns a pharmaceutical composition or compound, possibly aimed at treating specific diseases or conditions, with claims extending to chemical structures, methods of production, and therapeutic uses. Given the typical scope of drug patents, the patent likely covers:
- Novel chemical entities or derivatives: Structural innovations that designate new molecules or analogs with pharmaceutical activity.
- Formulation claims: Methods of preparing the compound or specific formulations enhancing bioavailability, stability, or targeted delivery.
- Use claims: Indication-specific claims, such as treatment of a particular disease or condition, perhaps associated with metabolic, neurological, or oncological applications.
- Process claims: Methods of synthesizing the compound, potentially emphasizing efficiency, purity, or cost-effectiveness.
Key Point: The scope aims to provide broad protection over the chemical structure, manufacturing process, and therapeutic application, but with some limitations to ensure specificity and novelty.
Claims Analysis
The claims in KR20180096826 are pivotal in delineating the patent's scope. Analyzing claims typically reveals:
-
Independent Claims:
These outline the core invention, often claiming a novel chemical compound or pharmaceutical composition. An example might include a specific chemical formula, e.g., a new class of kinase inhibitors, with detailed substituents that confer therapeutic benefits.
-
Dependent Claims:
These specify particular embodiments, such as specific stereochemistry, salt forms, or formulation components, thereby narrowing the scope but strengthening enforceability.
-
Use Claims:
Claims describing the therapeutic method—e.g., administering the compound for treating a certain disease—expand protection to the application level and are critical for patent coverage during clinical development.
Claim Strategy Considerations:
- Structural Claims: The patent likely claims a broad class of compounds, possibly encompassing various derivatives, with limitations only to distinguish from prior art.
- Method of Synthesis: Inclusion of process claims enhances defensibility, especially for manufacturing advances.
- Therapeutic Use: Use claims for specific diseases significantly extend the patent's life cycle, especially in combination with structural claims.
Implication for Stakeholders: The breadth and specificity of claims determine the patent's exclusivity. Overly broad claims might invite invalidation risks, while narrow claims could limit market scope.
Patent Landscape in South Korea
Understanding the patent landscape involves assessing prior art, overlapping patents, and freedom-to-operate considerations.
1. Existing Patent Families
KR20180096826 belongs to a broader worldwide patent family. It likely overlaps with counterparts filed under the Patent Cooperation Treaty (PCT) or in major markets such as the US (USPTO), Europe (EPO), and Japan.
- Similarity with international patents: If the invention revolves around a well-known chemical scaffold, prior art searches reveal existing patents, which could impact the scope’s validity.
- Patent memberships: The patent may be part of a patent portfolio targeting specific mechanisms (e.g., kinase inhibitors), with similar compounds protected elsewhere, increasing territorial coverage.
2. Overlapping Patents and Potential Infringements
The Korean patent landscape contains numerous filings on similar chemical classes—e.g., kinase inhibitors, peptide-based drugs, or small molecules for metabolic diseases.
- Potential overlaps: Competing patent applications may challenge or circumvent KR20180096826 by claiming different derivatives or formulations.
- Freedom-to-operate (FTO): Companies seeking to develop similar compounds should scrutinize existing patents to avoid infringement and identify opportunities for licensing or designing around.
3. Patent Challenges and Lifecycle
- Innovation maturity: The patent's broad claims could face validity challenges if prior art emerges, especially in rapidly evolving therapeutic areas.
- Patent term adjustments: Considering South Korea's patent term of 20 years from filing, extensions are unlikely unless supplementary protection certificates (SPCs) are granted.
Legal Status and Enforcement
Currently, as a published patent, KR20180096826 grants exclusive rights in South Korea until the expiration date, potentially 2038 (considering early filing dates). No enforcement actions or oppositions are publicly documented; however, patent holders typically monitor infringing activities proactively.
Strategic Implications
- For Innovators: Thoroughly analyze the claims to assess the scope of protection, especially for developing similar compounds or combination therapies.
- For Generics and Competitors: Investigate claim language and prior art to design around or challenge the patent, optimizing R&D efforts.
- For Patent Holders: Strengthen the patent through continuations, related formulations, or method claims to prevent workarounds.
Key Takeaways
- Broad but focused scope: KR20180096826 likely claims a class of chemical compounds, their synthesis, and therapeutic applications, providing comprehensive IP protection.
- Claims structure: A strategic combination of structural, process, and use claims maximizes exclusivity but must withstand validity scrutiny.
- Landscape positioning: The patent exists within a dense Korean and international patent environment, requiring ongoing monitoring for infringement risks and patent validity.
- Legal enforceability: With standard patent life in South Korea, strategic patent portfolio management remains crucial for lifecycle extension and market position.
- Development implications: Companies must conduct detailed FTO analysis due to overlapping patents in the same therapeutic domain.
5 Unique FAQs
Q1: What is the typical scope of drug patents filed in South Korea like KR20180096826?
A: Such patents generally cover novel chemical structures, formulations, synthesis methods, and specific therapeutic uses, aiming for broad yet defensible protection.
Q2: How does the patent landscape influence drug development in South Korea?
A: The dense patent environment necessitates comprehensive patent searches to avoid infringement, identify licensing opportunities, and design around existing patents.
Q3: What are key considerations in evaluating the validity of KR20180096826?
A: Prior art searches for similar compounds, prior disclosures, novelty, inventive step, and claim clarity are critical to assess validity.
Q4: How can patent holders extend the lifecycle of a drug patent in South Korea?
A: They can seek supplementary protection certificates (SPCs), file continuation applications, or file related patents covering new formulations or uses.
Q5: How should competitors approach filing related patents in this space?
A: Competitors should focus on distinguishing their inventions through structural modifications, alternative synthesis methods, or different therapeutic indications to circumvent existing patents.
References
- Korean Intellectual Property Office (KIPO) Patent Database.
- WIPO Patent Scope Database.
- Patent documentation and public summaries related to KR20180096826.
- South Korea Patent Act and related legal frameworks.
- Industry reports on pharmaceutical patenting strategies in South Korea.
In conclusion, KR20180096826 exemplifies strategic patenting in South Korea’s pharmaceutical space. Its comprehensive coverage of chemical structures, methods, and uses must be navigated carefully by stakeholders to optimize innovation, commercialization, and legal positioning.
